
Please try another search
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
Name | Age | Since | Title |
---|---|---|---|
R. Matthew Neff | 68 | 2017 | Independent Chairman |
Robert W. Leasure | 64 | 2019 | President, CEO & Director |
John E. Sagartz | 58 | 2018 | Chief Strategy Officer & Director |
David Landman | 68 | 2023 | Independent Director |
Nigel Brown | 59 | 2021 | Independent Director |
Michael J. Harrington | 62 | 2024 | Independent Director |
Mary Theresa Coelho | 62 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review